Multilevel botulinum toxin type a as a treatment for spasticity in children with cerebral palsy: a retrospective study
INTRODUCTION: Cerebral palsy is the most common cause of physical disability in children. Spasticity is a disabling clinical symptom that is prevalent among patients suffering from cerebral palsy. The treatment of spasticity with botulinum toxin type A (BTX-A) is a well-established option in the int...
שמור ב:
| Principais autores: | , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Elsevier España
2010-01-01
|
| סדרה: | Clinics |
| נושאים: | |
| גישה מקוונת: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322010000600009 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
